Pediatric patients with cystic fibrosis starting triple combination therapy had larger relative improvements in 129Xenon MRI ...
From 2008 to 2023, there has been a significant decrease in cystic fibrosis mortality rates and a significant rise in sickle ...
New research out of the University of Iowa is reshaping what it means to live with cystic fibrosis, a genetic disease that ...
The Company continues working with the third-party manufacturer to address recent FDA follow-up information requests which are required to lift ...
Dose-ranging trial evaluated deupirfenidone 550 mg three times a day (TID) (approximately equivalent exposure to pirfenidone 801 mg TID 1) and deupirfenidone 825 mg TID and successfully demonstrated ...
Breathing disorders are common in the U.S. with conditions like COPD affecting some 7% of the population and asthma affecting another 10%. Digestive conditions like GERD, acid reflux, Celiac disease ...
Findings showed treatment with nerandomilast led to a significant improvement in lung function compared with placebo. Topline data were announced from a phase 3 trial evaluating nerandomilast, an oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback